SUNPHARMA · Sun Pharmaceutical Ind Ltd · Biotechnology & Drugs
As of 06 Nov close
52-week range
9.1% below 52-week high
52-week range: as of 06 Nov 2026 close.
Slowest input: promoter pledge (disclosed quarterly), as of 18 Jul 2026
Stock Condition
Weighted combination of 8 measured readings. Not a probability, a rating or a forecast.
Stock Condition as of 06 Nov 2026 close
What the data shows
- Trend (10d)
- Sector standing
- Delivery (previous session)
- FII flow (5d)
- PCR
- RSI (14)
- Promoter pledge
- Insider activity (30d)
- Volume vs usual (5-day vs 20-day)
- 2.09x its usual level
- Growth trend
- Revenue grew 10.46% YoY last quarter (no multi-quarter acceleration streak on file).
- Valuation vs peers
- Trailing P/E of 37.84 sits inline the sector average of 36.32.
- Event risk (5d)
Data as of 06 Nov 2026
Data as of 06 Nov 2026
Data as of 05 Nov 2026
Data timestamp unavailable
Data as of 06 Nov 2026
Data as of 06 Nov 2026
Data as of 18 Jul 2026
Data timestamp unavailable
Data as of 06 Nov 2026
Data timestamp unavailable
Data timestamp unavailable
Data as of 02 Nov 2026 · 06:45 am IST
Signal changes and why the Stock Condition changed
Why did this change?
SUNPHARMA's Stock Condition rose from 53 to 62 on 6 Nov (+9).
- ▲Price trend: Trend reading improved vs yesterday
- ▼Volume participation: volume participation eased
- –Delivery participation: delivery held steady
- ▲Momentum (RSI): RSI moved higher
- ▲Sector standing: industry standing improved
- ▲Options positioning (PCR): options positioning shifted more put-heavy
- –Promoter pledge: promoter pledge unchanged
- –Insider activity: insider filings unchanged
- ▲FII flow context: FII flow backdrop improved
▲ improved · ▼ weakened · – unchanged
The data shows the change but not its cause — several explanations are usually possible.
Signal Change Log
- 06 Nov+9Stock Condition rose 9 points on shifts across underlying measured values
- 05 Nov+410-day trend turned positive
- 05 Nov+4price held above its 20-day average
- 04 Nov+8Stock Condition rose 8 points on shifts across underlying measured values
- 03 Nov-5FII flows ran net-positive
- 03 Nov-5classified news events were recorded
- 03 Nov-5delivery state cleared (delivery down no longer applied)
- 02 Nov-13delivery signal weakened
- 02 Nov-13volume ran above its recent norm
- 30 Oct+16trend state cleared (below 20dma no longer applied)
- 29 Oct-3Stock Condition eased 3 points on shifts across underlying measured values
- 27 Oct+17event state cleared (event risk no longer applied)
- 26 Oct-3Stock Condition eased 3 points on shifts across underlying measured values
- 23 Oct+3Stock Condition rose 3 points on shifts across underlying measured values
- 22 Oct+8trend state cleared (trend down 10d no longer applied)
- 22 Oct+8fii state cleared (fii sell streak no longer applied)
- 21 Oct-1910-day trend turned negative
- 21 Oct-19classified news events were recorded
- 16 Oct+3trend state cleared (trend down 10d no longer applied)
- 16 Oct+3options state cleared (pcr call heavy no longer applied)
- 15 Oct+7Stock Condition rose 7 points on shifts across underlying measured values
- 14 Oct-1options positioning turned call-heavy
- 13 Oct-1options state cleared (pcr call heavy no longer applied)
- 12 Oct+2options positioning turned call-heavy
- 09 Oct-8Stock Condition eased 8 points on shifts across underlying measured values
- 08 Oct+3Stock Condition rose 3 points on shifts across underlying measured values
Related news
- lowtrendhunter.com· 02 Nov 2026, 11:03 pmClinic-Delivered Psoriatic Arthritis Biologic
- highregulatorythehindubusinessline.com· 02 Nov 2026, 08:52 pmCipla tops drug overcharging dues with ₹3,576 crore; J&J, Ranbaxy among top five
- lowthehindubusinessline.com· 02 Nov 2026, 02:06 pmSun Pharma slides nearly 2% as Ilumya concerns weigh on analyst estimates
- unknowneconomictimes.indiatimes.com· 02 Nov 2026, 06:45 amSun Pharma’s specialty portfolio, Organon deal to drive growth
- unknownlivemint.com· 31 Oct 2026, 05:34 pmOphthalmic products recalled: Why drug regulators ordered Sun Pharma to halt eye-drop production at Assam plant?
- unknowneconomictimes.indiatimes.com· 31 Oct 2026, 09:31 amSun Pharma Q2 profit takes a hit on exceptional items